Cardiac fibrosis: potential therapeutic targets

S Park, NB Nguyen, A Pezhouman, R Ardehali - Translational Research, 2019 - Elsevier
Cardiovascular disease is a leading cause of mortality in the world and is exacerbated by
the presence of cardiac fibrosis, defined by the accumulation of noncontractile extracellular …

[HTML][HTML] Milestones and current achievements in development of multifunctional bioscaffolds for medical application

J Litowczenko, MJ Woźniak-Budych, K Staszak… - Bioactive materials, 2021 - Elsevier
Tissue engineering (TE) is a rapidly growing interdisciplinary field, which aims to restore or
improve lost tissue function. Despite that TE was introduced more than 20 years ago …

Scaffolds with covalently immobilized VEGF and Angiopoietin-1 for vascularization of engineered tissues

LLY Chiu, M Radisic - Biomaterials, 2010 - Elsevier
The aim of this study was to engineer a biomaterial capable of supporting vascularization in
vitro and in vivo. We covalently immobilized vascular endothelial growth factor (VEGF) and …

Electroactive graphene oxide‐incorporated collagen assisting vascularization for cardiac tissue engineering

MH Norahan, M Amroon… - … research Part A, 2019 - Wiley Online Library
The application of a cardiac patch over the epicardial surface has shown positive effects in
protecting cardiac function postinfarction. Electroactive patches could enhance electrical …

Engineering the heart: evaluation of conductive nanomaterials for improving implant integration and cardiac function

J Zhou, J Chen, H Sun, X Qiu, Y Mou, Z Liu, Y Zhao… - Scientific reports, 2014 - nature.com
Recently, carbon nanotubes together with other types of conductive materials have been
used to enhance the viability and function of cardiomyocytes in vitro. Here we demonstrated …

Biomaterials for the treatment of myocardial infarction: a 5-year update

AA Rane, KL Christman - Journal of the American College of Cardiology, 2011 - jacc.org
The first review on biomaterials for the treatment of myocardial infarction (MI) was written in
2006. In the last 5 years, the general approaches for biomaterial treatment of MI and …

[PDF][PDF] RETRACTED: Poly (lactic–co-glycolic acid): Carbon nanofiber composites for myocardial tissue engineering applications

DA Stout, B Basu, TJ Webster - 2011 - iitk.ac.in
abstract The objective of the present in vitro research was to investigate cardiac tissue cell
functions (specifically cardiomyocytes and neurons) on poly (lactic–co-glycolic …

Role of biomaterials in cardiac repair and regeneration: therapeutic intervention for myocardial infarction

U Tariq, M Gupta, S Pathak, R Patil… - ACS Biomaterials …, 2022 - ACS Publications
Heart failure or myocardial infarction (MI) is one of the world's leading causes of death. Post
MI, the heart can develop pathological conditions such as ischemia, inflammation, fibrosis …

Role of hyaluronan in angiogenesis and its utility to angiogenic tissue engineering

EL Pardue, S Ibrahim, A Ramamurthi - Organogenesis, 2008 - Taylor & Francis
Angiogenesis represents the outgrowth of new blood vessels from existing ones, a
physiologic process that is vital to supply nourishment to newly forming tissues during …

[图书][B] Understanding mechanisms by which injectable biomaterials affect cardiac function post-myocardial infarction

AA Rane - 2012 - search.proquest.com
Cardiovascular disease affects over 82 million Americans, of which myocardial infarction
(MI) and subsequent heart failure (HF) patients are a major subset. As a result, the …